Switch back to WCC classic look
WCC's Collection of COVID-19 information

WorkCompCentral – Workers' Compensation Education, Courses, News and Information

Call or email us anytime
(805) 484-0333
Search Guide
Today is Wednesday, May 27, 2020 -

News Articles

Ametros Enhances Drug Monitoring Program

  • National
  • Topic: NATIONAL
  • -  213 views
  • - Average time spent on item: 7 minutes
  • - Popular with: Legal
  • -  1 share

Ametros said it expanded its drug monitoring program to track the use of controlled substances on Medicare Set-Asides it administers, following new guidance from the Centers for Medicare and Medicaid Services.

CMS recently updated Version 3.0 of its Workers’ Compensation Medicare Set-Aside Arrangement Reference Guide to “highly recommend” professional administration in cases where a claimant is taking opioids, benzodiazepines and other “frequently abused drugs.”

Ametros said it expanded its drug monitoring program protocol, incorporating new recommendations so the program now:

  • Alerts pharmacists when a CareGuard member is receiving both opioids and benzodiazepines.
  • Periodically monitors CareGuard members who meet CMS-recommended guidelines for high opioid usage. In these cases, there will be coordinated communication with the member and their prescribers.
  • Alerts pharmacists to high opioid use, including multiple opioids.

Ametros provides pharmacy discounts and clinical management services as part of its CareGuard program for its members, who are patients with medical settlements resulting from personal injuries.

No Comments

Log in to post a comment

Close


Do not post libelous remarks. You are solely responsible for the postings you input. By posting here you agree to hold harmless and indemnify WorkCompCentral for any damages and actions your post may cause.

Featured Video

Upcoming Events

Workers' Compensation Events

Social Media Links


WorkCompCentral Workers' Compensation
News and Education
4081 Mission Oaks Blvd
Camarillo, CA 93012
(805) 484-0333